Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in ARDX — Ardelyx, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,671,788
+$467,000 QoQ
Shares Held
916,037
+30.5% QoQ
Ownership
0.368%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 250 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Derivatives in ARDX

reported options exposure · as of Jun 30, 2026
CallValue
$1,558,560
CallShares
305,600
PutValue
$2,033,880
PutShares
398,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. ARDX ranks #52 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in ARDX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,671,788 916,037
2026-06-30 $2,033,880 398,800
2026-06-30 $1,558,560 305,600
2026-03-31 $1,982,690 331,000
2026-03-31 $4,204,788 701,968
2026-03-31 $1,490,312 248,800
2025-12-31 $1,098,372 188,400
2025-12-31 $1,971,123 338,100
2025-12-31 $4,525,274 776,205
2025-09-30 $1,649,694 299,400
2025-09-30 $3,416,227 620,005
2025-09-30 $1,335,624 242,400
2025-06-30 $1,016,064 259,200
2025-06-30 $3,705,512 945,284
2025-06-30 $771,456 196,800
2025-03-31 $5,417,320 1,103,324
2025-03-31 $1,352,705 275,500
2025-03-31 $1,065,470 217,000
2024-12-31 $5,001,265 986,443
2024-12-31 $2,115,204 417,200
2024-12-31 $3,143,400 620,000
2024-09-30 $11,998,872 1,741,491
2024-09-30 $2,018,081 292,900
2024-09-30 $2,952,365 428,500
2024-06-30 $3,652,389 492,900
2024-06-30 $9,005,891 1,215,370
2024-06-30 $5,232,942 706,200
2024-03-31 $11,949,559 1,636,926
2024-03-31 $4,303,350 589,500
2024-03-31 $5,623,190 770,300
2023-12-31 $16,054,788 2,589,482
2023-12-31 $4,464,000 720,000
2023-12-31 $4,271,180 688,900
2023-09-30 $4,170,168 1,022,100
2023-09-30 $187,272 45,900
2023-09-30 $9,510,276 2,330,950
2023-06-30 $6,202,896 1,829,763
2023-06-30 $2,892,687 853,300
2023-06-30 $864,111 254,900
2023-03-31 $6,002,828 1,253,200
2023-03-31 $3,481,372 726,800
2023-03-31 $19,760,172 4,125,297
2022-12-31 $2,463,540 864,400
2022-12-31 $4,046,142 1,419,699
2022-12-31 $3,664,815 1,285,900
2022-09-30 $918,204 771,600
2022-09-30 $1,520,546 1,277,770
2022-09-30 $1,022,924 859,600
2022-06-30 $410,341 695,494
2022-06-30 $315,060 534,000